Method for stabilizing anti-dementia drug
The present invention, by adding a high molecular weight acidic substance in the pharmaceutical composition containing the anti-dementia drug and the high molecular weight basic substance, and provides a method for stabilizing the anti-dementia drug in the pharmaceutical composition. Furthermore, the present invention provides a pharmaceutical composition containing for stabilizing the anti-dementia drug and a high molecular weight containing a basic substance and the high molecular weight acidic substance anti-dementia drug. Furthermore, the present invention provides an anti-dementia drug and a high molecular weight pharmaceutical composition manufacturing method comprising the steps to be added to the mixture of the basic substance to stabilize the high molecular weight acidic the solution or suspension containing the anti-dementia drug substance. Anti-dementia drug, the high molecular weight basic substance, the high molecular weight acidic substance, sustained-release preparation
Despite the fact that since 1985 the government of Quebec increased by 5.75 % on average the amount of money spent on healthcare per year, little improvement was noted. It is obvious that an optimal use of resources is essential to reduce waiting times and provide safer and faster services to patients. The use of new technology can contribute to improve the healthcare system efficiency. Our study aims to assess the impact of a medication distribution technology on 1) the performance of a health and social services center’s pharmacy, 2) the performance of one care unit in a nursing home and on 3) the medication-use process safety. To measure performance we were inspired by the Lean approach. The results show that medication distribution technology is considered as an effective way to significantly detect medication errors, to allow nurses to focus more on patients and pharmacy to react more rapidly to changes in patient medications.